Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19) Ivan Lopez-Mendez; Jorge Aquino-Matus; Sofia Murua-Beltrán Gall; Jose D. Prieto-Nava; Eva Juarez-Hernandez; Misael Uribe; Graciela Castro-Narro;

Is FIB-4 the right tool for screening for liver fibrosis? Leen JM. Heyens; Demi P.A.van Malde; Gediz Dogay Us; Francesco Innocenti; Mathieu Struyve; Christophe Van Steenkiste; Sven Francque; Geert Robaeys; Ger H. Koek;

Genetic risk factors for MASLD/MASH and cardiovascular disease in elderly individuals Willy B. Theel; Vivian D. de Jong; Diederick E. Grobbee; J. Wouter Jukema; Stella Trompet; Manuel Castro Cabezas;